OTC antibody
GTX105140
ApplicationsWestern Blot, ImmunoHistoChemistry, ImmunoHistoChemistry Frozen, ImmunoHistoChemistry Paraffin
Product group Antibodies
TargetOTC
Overview
- SupplierGeneTex
- Product NameOTC antibody
- Delivery Days Customer9
- Application Supplier NoteWB: 1:500-1:30000. IHC-P: 1:100-1:1000. *Optimal dilutions/concentrations should be determined by the researcher.Not tested in other applications.
- ApplicationsWestern Blot, ImmunoHistoChemistry, ImmunoHistoChemistry Frozen, ImmunoHistoChemistry Paraffin
- CertificationResearch Use Only
- ClonalityPolyclonal
- Concentration0.65 mg/ml
- ConjugateUnconjugated
- Gene ID5009
- Target nameOTC
- Target descriptionornithine transcarbamylase
- Target synonymsOCTD, OTC1, OTCD, OTCase, ornithine transcarbamylase, mitochondrial, ornithine carbamoyltransferase, mitochondrial
- HostRabbit
- IsotypeIgG
- Protein IDP00480
- Protein NameOrnithine transcarbamylase, mitochondrial
- Scientific DescriptionThis nuclear gene encodes a mitochondrial matrix enzyme. Missense, nonsense, and frameshift mutations in this enzyme lead to ornithine transcarbamylase deficiency, which causes hyperammonemia. Since the gene for this enzyme maps close to that for Duchenne muscular dystrophy, it may play a role in that disease also. [provided by RefSeq]
- Storage Instruction-20°C or -80°C,2°C to 8°C
- UNSPSC12352203
References
- Chida T, Ishida Y, Morioka S, et al. Persistent hepatic IFN system activation in HBV-HDV infection determines viral replication dynamics and therapeutic response. JCI Insight. 2023,8(9). doi: 10.1172/jci.insight.162404Read this paper
- Sugahara G, Yamasaki C, Yanagi A, et al. Humanized liver mouse model with transplanted human hepatocytes from patients with ornithine transcarbamylase deficiency. J Inherit Metab Dis. 2021,44(3):618-628. doi: 10.1002/jimd.12347Read this paper
- Wang X, Yuan Y, Didelija IC, et al. Ex Vivo Enteroids Recapitulate In Vivo Citrulline Production in Mice. J Nutr. 2018,148(9):1415-1420. doi: 10.1093/jn/nxy126Read this paper
- Agrawal V, Woo JH, Mauldin JP, et al. Cytotoxicity of human recombinant arginase I (Co)-PEG5000 in the presence of supplemental L-citrulline is dependent on decreased argininosuccinate synthetase expression in human cells. Anticancer Drugs. 2012,23(1):51-64. doi: 10.1097/CAD.0b013e32834ae42bRead this paper




